These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23747137)

  • 1. Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?
    Rimareix F; Bauduceau B
    Ann Endocrinol (Paris); 2013 Jul; 74(3):207-10. PubMed ID: 23747137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of hyperglycaemia of type 2 diabetes. Paradigm change according to the ADA-EASD consensus report 2018].
    Scheen AJ; Paquot N
    Rev Med Liege; 2018 Dec; 73(12):629-633. PubMed ID: 30570234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2015 updated position statement of the management of hyperglycaemia in type 2 diabetes].
    Scheen AJ; Paquot N
    Rev Med Suisse; 2015 Aug; 11(483):1518, 1520-5. PubMed ID: 26502577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?
    Czupryniak L
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S22-5. PubMed ID: 20115928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.
    Schernthaner G; Barnett AH; Betteridge DJ; Carmena R; Ceriello A; Charbonnel B; Hanefeld M; Lehmann R; Malecki MT; Nesto R; Pirags V; Scheen A; Seufert J; Sjohölm A; Tsatsoulis A; DeFronzo R
    Diabetologia; 2010 Jul; 53(7):1258-69. PubMed ID: 20352408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for the management of diabetes mellitus type 2].
    Mediavilla Bravo JJ
    Semergen; 2014 Sep; 40 Suppl 4():11-8. PubMed ID: 25595348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
    Diabetes Care; 2018 Dec; 41(12):2669-2701. PubMed ID: 30291106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Buse JB; Wexler DJ; Tsapas A; Rossing P; Mingrone G; Mathieu C; D'Alessio DA; Davies MJ
    Diabetes Care; 2020 Feb; 43(2):487-493. PubMed ID: 31857443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR; ;
    Diabetes Care; 2012 Jun; 35(6):1364-79. PubMed ID: 22517736
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
    Barnett A
    Int J Clin Pract Suppl; 2007 Aug; (154):12-8. PubMed ID: 17593273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
    Diabetologia; 2018 Dec; 61(12):2461-2498. PubMed ID: 30288571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of publishing medical specialty society guidelines on subsequent adoption of best practices: a case study with type 2 diabetes.
    Huang EA; Zdon GS; Moore RJ; Jane Moran H; Quick WW
    Int J Clin Pract; 2010 Apr; 64(5):558-61. PubMed ID: 20456210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cryer PE
    Diabetologia; 2007 Jan; 50(1):222-4; discussion 225-30; author reply 231-3. PubMed ID: 17047916
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Woo V;
    Diabetes Care; 2009 Mar; 32(3):e34; author reply e37-8. PubMed ID: 19246585
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient-centred care in type 2 diabetes mellitus - Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report.
    Fritzen K; Stautner C; Schnell O
    Diabetes Res Clin Pract; 2019 Dec; 158():107897. PubMed ID: 31672502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control and implementation of the ADA/EASD-2006 consensus algorithm in type 2 diabetes mellitus patients in primary care in Spain.
    Alvarez-Guisasola F;
    Int J Clin Pract; 2014 Jan; 68(1):28-39. PubMed ID: 24341300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Schwartz SS
    Curr Med Res Opin; 2013 Jul; 29(7):793-9. PubMed ID: 23614630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2015 Mar; 58(3):429-42. PubMed ID: 25583541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.